Status:
COMPLETED
Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO
Lead Sponsor:
Technische Universität Dresden
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of this study is to describe the regional and global tumor hypoxia in head-and-neck cancer during percutaneous radiation therapy
Eligibility Criteria
Inclusion
- histologically confirmed head-and-neck cancer not curable by surgery
- Karnofsky \> 70%
- tumor volume and localisation allow curative radiotherapy
- written consent
Exclusion
- metastases
- earlier radiation therapy of head and neck
- pregnancy
- secondary malignancy excluding dermal carcinoma and Tis-carcinoma of cervix uteri
- psychiatric impairment
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00180180
Start Date
July 1 2006
End Date
October 1 2018
Last Update
March 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nuclear Medicine
Dresden, Germany, 01307